N-(2-Chlorobenzyl)-1-phenylpropan-2-amine hydrochloride

CAS : 5843-53-8

Ref. 3D-FC131572

Informations sur le produit

• Nom: N-(2-Chlorobenzyl)-1-phenylpropan-2-amine hydrochloride
• Synonymes: (2-Chlorobenzyl)(1-methyl-2-phenylethyl)amine hydrochloride, (+)-N-(o-Chlorobenzyl)-alpha-methylphenethylamine hydrochloride, Asenlix, Ba 7205, Benzeneethanamine, N-[(2-chlorophenyl)methyl]-α-methyl-, hydrochloride (1:1), (+)-, Benzeneethanamine, N-[(2-chlorophenyl)methyl]-α-methyl-, hydrochloride, (+)-, Chlorhydrate de d-N-(phenyl-1 propyl-2) chloro-2 benzylamine, Chlorhydrate de d-N-(phenyl-1 propyl-2) chloro-2 benzylamine [French], Clobenzorex HCl, Clobenzorex hydrochloride, Dinintel, N-(2-chlorobenzyl)-1-phenylpropan-2-amine hydrochloride (1:1), Phenethylamine, N-(o-chlorobenzyl)-alpha-methyl-, hydrochloride, (+)-, Phenethylamine, N-(o-chlorobenzyl)-α-methyl-, hydrochloride, (+)-, Rexigen, Sd 271-12

Description

N-(2-Chlorobenzyl)-1-phenylpropan-2-amine hydrochloride (CBP) is a potent stimulant drug that is used to treat chronic pain. It has been shown to be effective in the treatment of alopecia areata and inflammatory diseases, such as Crohn's disease, ulcerative colitis, and rheumatoid arthritis. CBP blocks protein synthesis by inhibiting the activity of the enzyme dinucleotide phosphate (DNP). This inhibition leads to the accumulation of adenosine monophosphate (AMP), which inhibits cyclic AMP production and protein synthesis. CBP also prevents the binding of DNP to RNA polymerase II at promoter sites, leading to a decrease in mRNA production. As a result, CBP may inhibit protein synthesis by preventing transcription or translation.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 296.24 g/mol
• Formule: C₁₆H₁₈ClN•HCl
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder